Skip to content

Audrey Bettina Miklius, M.D.

NPI 1689628257ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Dallas, TX

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Dallas, Texas, trained at University of Hawaii John A. Burns School of Medicine (class of 1988). Their prescriptions cost Medicare Part D more than their services did: $2,231,725 for 5,694 claims, against $155,103 paid for services in 2024. Novo Nordisk Inc was the largest of 35 companies reporting payments in 2025, $4,374 in all, mostly food and beverage.

Overview

NPI1689628257
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMay 19, 2006
Last updated in NPPESSep 23, 2021
Certified by providerSep 23, 2021

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (TX)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients598
Services billed5,339 across 50 procedure codes
Paid by Medicare$155,103

Part D prescriptions in 2024

Prescriptions (claims)5,694 · 13,798 30-day fills
Patients559
Total drug cost$2,231,725
Generic share54% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of Hawaii John A. Burns School of Medicine
Graduation year1988
Medicare specialtyEndocrinology
Secondary specialtiesInternal Medicine
TelehealthOffers telehealth

Medical group

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$4,374 · 181 payments from 35 companies
  • 2024$3,258 · 162 payments from 32 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$1,09243
Medtronic, Inc.$442.5416
Neurocrine Biosciences, Inc.$338.948
Abbott Laboratories$179.988
Amgen Inc.$177.1810

What the 2025 payments were for

  • Food and Beverage$3,955 · 168 payments
  • Education$419.51 · 13 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Dallas

All 102 endocrinologists in Dallas · All endocrinologists in Texas